MET in ovarian cancer: Metastasis and resistance?

por Tang, Chad, Jardim, Denis L, Hong, David
Publicado 2014

Comprehensive characterization of malignant phyllodes tumor by whole genomic and proteomic analysis: biological implications for targeted therapy opportunities

por Jardim, Denis L Fontes, Conley, Anthony, Subbiah, Vivek
Publicado 2013

An appraisal of drug development timelines in the Era of precision oncology

por Jardim, Denis Leonardo, Schwaederle, Maria, Hong, David S., Kurzrock, Razelle
Publicado 2016

Lessons From the Development of the Immune Checkpoint Inhibitors in Oncology

por Jardim, Denis L., de Melo Gagliato, Débora, Kurzrock, Razelle
Publicado 2018

MET alterations detected in blood-derived circulating tumor DNA correlate with bone metastases and poor prognosis

por Ikeda, Sadakatsu, Schwaederle, Maria, Mohindra, Mandakini, Fontes Jardim, Denis L., Kurzrock, Razelle
Publicado 2018

PD-L1 gene amplification and focality: relationship with protein expression

por Jardim, Denis Leonardo, Murugesan, Karthikeyan, Elvin, Julia A., Huang, Richard S. P., Kurzrock, Razelle
Publicado 2023

Robot - assisted laparoscopic retroperitoneal lymph node dissection in testicular tumor

por Torricelli, Fabio C. M., Jardim, Denis, Guglielmetti, Giuliano B., Patel, Vipul, Coelho, Rafael F.
Publicado 2017

Efficacy and safety of anticancer drug combinations: a meta-analysis of randomized trials with a focus on immunotherapeutics and gene-targeted compounds

por Jardim, Denis L., De Melo Gagliato, Débora, Nikanjam, Mina, Barkauskas, Donald A., Kurzrock, Razelle
Publicado 2020

Mechanisms of resistance and sensitivity to anti-HER2 therapies in HER2+ breast cancer

por de Melo Gagliato, Debora, Leonardo Fontes Jardim, Denis, Marchesi, Mario Sergio Pereira, Hortobagyi, Gabriel N.
Publicado 2016

Bevacizumab as First-Line Therapy in Advanced Non-Small-Cell Lung Cancer: A Brazilian Center Experience

por Jardim, Denis Leonardo Fontes, de Melo Gagliato, Débora, Ribeiro, Karina Braga, Shimada, Andrea Kazumi, Katz, Artur
Publicado 2012

Phase I trials of antitumour agents: fundamental concepts

por Toloi, Diego de Araujo, Jardim, Denis Leonardo Fontes, Hoff, Paulo Marcelo Gehm, Riechelmann, Rachel Simões Pimenta
Publicado 2015

Comprehensive Landscape of Cyclin Pathway Gene Alterations and Co-occurrence with FGF/FGFR Aberrations Across Urinary Tract Tumors

por Jardim, Denis L F, Millis, Sherri Z, Ross, Jeffrey S, Lippman, Scott, Ali, Siraj M, Kurzrock, Razelle
Publicado 2022

Circulating Tumor DNA Detection in the Management of Anti-EGFR Therapy for Advanced Colorectal Cancer

por Knebel, Franciele H., Bettoni, Fabiana, da Fonseca, Leonardo G., Camargo, Anamaria A., Sabbaga, Jorge, Jardim, Denis L.
Publicado 2019

Cyclin Pathway Genomic Alterations Across 190,247 Solid Tumors: Leveraging Large‐Scale Data to Inform Therapeutic Directions

por Jardim, Denis L., Millis, Sherri Z., Ross, Jeffrey S., Woo, Michelle Sue‐Ann, Ali, Siraj M., Kurzrock, Razelle
Publicado 2020

Landscape of Cyclin Pathway Genomic Alterations Across 5,356 Prostate Cancers: Implications for Targeted Therapeutics

por Jardim, Denis L., Millis, Sherri Z., Ross, Jeffrey S., Woo, Michelle Sue‐Ann, Ali, Siraj M., Kurzrock, Razelle
Publicado 2021

Phosphatidylinositol 3‐kinase pathway genomic alterations in 60,991 diverse solid tumors informs targeted therapy opportunities

por Millis, Sherri Z., Jardim, Denis L., Albacker, Lee, Ross, Jeffrey S., Miller, Vincent A., Ali, Siraj M., Kurzrock, Razelle
Publicado 2018

Cardiovascular toxicity following immune checkpoint inhibitors: A systematic review and meta-analysis

por Xavier, Camila Bragança, Lopes, Carlos Diego Holanda, Harada, Guilherme, Peres, Eduardo Dante Bariani, Katz, Artur, Jardim, Denis Leonardo
Publicado 2022

Choice of 16S Ribosomal RNA Primers Impacts Male Urinary Microbiota Profiling

por Heidrich, Vitor, Inoue, Lilian T., Asprino, Paula F., Bettoni, Fabiana, Mariotti, Antonio C. H., Bastos, Diogo A., Jardim, Denis L. F., Arap, Marco A., Camargo, Anamaria A.
Publicado 2022

Interplay between Tumor Mutational Burden and Mutational Profile and Its Effect on Overall Survival: A Pilot Study of Metastatic Patients Treated with Immune Checkpoint Inhibitors

por Xavier, Camila B., Lopes, Carlos Diego H., Awni, Beatriz M., Campos, Eduardo F., Alves, João Pedro B., Camargo, Anamaria A., Guardia, Gabriela D. A., Galante, Pedro A. F., Jardim, Denis L.
Publicado 2022

FBXW7 Mutations in Patients with Advanced Cancers: Clinical and Molecular Characteristics and Outcomes with mTOR Inhibitors

por Jardim, Denis L., Wheler, Jennifer J., Hess, Kenneth, Tsimberidou, Apostolia M., Zinner, Ralph, Janku, Filip, Subbiah, Vivek, Naing, Aung, Piha-Paul, Sarina A., Westin, Shannon N., Roy-Chowdhuri, Sinchita, Meric-Bernstam, Funda, Hong, David S.
Publicado 2014